Head and Neck

May 6, 2016 by admin

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(LHRI) RADIO/Cisplatin Hearing Loss/Cisplatin HD vs LDRandomized Assessment of Cisplatin Dosing Interval for Ototoxicity in the treatment of locally advanced head and neck squamous cell carcinoma (LAHNSCC) undergoing curative concurrent chemoradiotherapy (RADIO)Meyers, Dr BrandonOpen to recruitmentNCT03649048
(CCTG) HN.9/LA-OSCCRandomized Phase II Study of Cisplatin plus Radiotherapy versus Durvalumab plus Radiotherapy followed by Adjuvant Durvalumab versus Durvalumab plus Radiotherapy followed by Adjuvant Tremelimumab and Durvalumab in Intermediate Risk HPV-Positive Locoregionally Advanced Oropharyngeal Squamous Cell Cancer (LA-OSCC)Meyers, Dr BrandonSuspended/On holdNCT03410615
Download PDF
Juravinski Cancer Centre Logo for printing

Find a Trial

As you consider your treatment options, there may be a clinical trial that is right for you, here at the Juravinski Cancer Centre.
Find a Trial


Hamilton Health Sciences Logo JCC Logo McMaster Logo ECRI Logo 3CTN Logo

Privacy Statement

Copyright 2016 Hamilton Health Sciences • Hamilton, Ontario

Back to top